Codexis Newswire

Comprehensive Real-Time News Feed for Codexis.

Results 1 - 20 of 25 in Codexis

  1. Gordon Sangster To Join Codexis, Inc. As Senior Vice President & Chief Financial OfficerRead the original story

    Yesterday | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief Financial Officer.

    Comment?

  2. Codexis' CEO Presents at Corporate ConferenceRead the original story

    Tuesday Jul 15 | Seeking Alpha

    Good day ladies and gentlemen and welcome to Codexis' Special Investor Conference call.

    Comment?

  3. GlaxoSmithKline will pay up to $25 million for protein-engineering techRead the original story w/Photo

    Monday Jul 14 | SFGate

    British pharmaceutical giant GlaxoSmithKline will pay up to $25 million, plus potential additional payments, to use the protein-engineering technology of Redwood City company Codexis, the companies said Monday.

    Comment?

  4. Codexis (CDXS) Multimillion-Dollar Protein Engineering Platform...Read the original story

    Tuesday Jul 15 | I-Newswire.com

    ... and the production of toxic waste, and reduce the energy intensity of the process. Pharmaceutical manufacturers use Codexis' (CDXS) biotechnology platform to increase purity and yields and produce less toxic waste. Codexis (CDXS) reported the ...

    Comment?

  5. Morning Market MoversRead the original story

    Tuesday Jul 15 | Benzinga

    Codexis rose 82.27% to $2.57 after the company announced the signing of a platform technology license agreement with GlaxoSmithKline .

    Comment?

  6. GSK invests up to $25M in new drug manufacturing technology - in Pa., not N.C.Read the original story w/Photo

    Tuesday Jul 15 | Local Tech Wire

    ... costs and improving sustainability. In a deal announced Monday, GSK (NYSE: GSK ) and Redwood, Calif.-based Codexis (Nasdaq: CDXS ) announced the licensing deal for "CodeEvolver," a protein engineering technology. Another $38.5 million could also be ...

    Comment?

  7. GlaxoSmithKline Invests Up To $25 Million In Codexis, Inc.'s New Drug Manufacturing TechnologyRead the original story

    Tuesday Jul 15 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the signing of a platform technology license agreement with GlaxoSmithKline .

    Comment?

  8. Targacept's Key Drug Failed Phase 2b Trial; ARIAD Announces...Read the original story

    Monday Jul 14 | Hispanic Business

    In the trial, TC-1734 did not meet the objective of showing superiority to donepezil, the marketed medication most often prescribed for Alzheimer's disease, after 52 weeks of treatment.

    Comment?

  9. Codexis +84% AH on Glaxo licensing pactRead the original story

    Monday Jul 14 | Seeking Alpha

    Codexis +84.4% AH on news it granted a license to GlaxoSmithKline to use its CodeEvolver platform technology to develop enzymes for use in pharmaceutical and health care products.

    Comment?

  10. Synthetic Biology Market Is Expected to Reach $38.7 Billion,...Read the original story

    Jun 5, 2014 | SBWire

    ... of the strategic moves by key companies. Companies profiled in the report include BASF, GEN9 Inc., Algenol Biofuels, Codexis Inc., Gensript Corporation, Dupont, Butamax Advanced Biofuels, BioAmber, BioSearch Technologies, Inc., Origene Technologies, ...

    Comment?

  11. Clean tech and The StreetRead the original story w/Photo

    Apr 4, 2010 | Examiner.com

    ... that are registering to become publically traded entities. Some high profile ones are Tesla Motors , Solyndra and Codexis . Up to this point, the primary methods of funding green companies have been through the personal fortunes of the avant-garde ...

    Comment?

  12. Codexis, Inc. Reports Financial Results For The First Quarter Of 2014Read the original story

    May 8, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the first quarter ended March 31, 2014.

    Comment?

  13. Codexis (CDXS) Announces Quarterly ResultsRead the original story

    May 7, 2014 | AmericanBankingNews.com

    Codexis released its earnings data on Wednesday. The company reported EPS for the quarter, missing the Thomson Reuters consensus estimate of by $0.07, American Banking News.com reports.

    Comment?

  14. Codexis' (CDXS) CEO John Nicols on Q1 2014 Results - Earnings Call TranscriptRead the original story

    May 7, 2014 | Seeking Alpha

    Welcome to Codexis' first quarter earnings conference call. I would now like to turn the call over to Doug Sheehy, Codexis' Executive Vice President, Chief Administrative Officer, General Counsel and Secretary.

    Comment?

  15. Codexis (CDXS) Set to Announce Earnings on WednesdayRead the original story

    May 6, 2014 | AmericanBankingNews.com

    Codexis will be posting its quarterly earnings results on Wednesday, May 7th. Parties interested in registering for the company's conference call can do so using this link .

    Comment?

  16. Codexis, Inc. To Announce First Quarter 2014 Financial Results On May 7, 2014Read the original story

    Apr 30, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, May 7, 2014 at 4:30 p.m. Eastern Time to discuss its first quarter 2014 financial results.

    Comment?

  17. LifeSci Advisors Initiates Coverage Of Codexis, Inc.Read the original story

    Apr 21, 2014 | BioSpace

    LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Codexis, Inc. , a leader in biocatalysis focused on using their enzyme engineering platform to streamline chemical transformations for the pharmaceutical and fine chemicals ... (more)

    Comment?

  18. Codexis, Inc. Sells Its Hungarian Operations To Intrexon CorporationRead the original story

    Mar 14, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation.

    Comment?

  19. Codexis Sells Its Hungarian Operations to Intrexon CorporationRead the original story

    Mar 13, 2014 | GlobeNewswire

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation.

    Comment?

  20. Codexis, Inc. Reports Fourth Quarter And Full Year 2013 ResultsRead the original story

    Mar 12, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013.

    Comment?